Advisory Services Network, LLC Immuno Gen, Inc. Transaction History

Advisory Services Network, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$12.46 - $29.95 $0 - $0	0 New	0 $0
Q1 2021 May 24, 2021	SELL	$6.5 - $10.53 $0 - $0	0 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$3.7 - $7.66 $14 - $30	-4 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.45 - $4.89 $13 - $19	4 New	4 $0
Q2 2018 Jul 27, 2018	SELL	$9.52 - $12.15 $102,816 - $131,220	-10,800 Closed	0 $0
Q1 2018 Apr 23, 2018	SELL	$6.7 - $12.95 $1,085 - $2,097	-162 Reduced 1.48%	10,800 $0
Q4 2017 Feb 08, 2018	BUY	$5.07 - $7.92 $55,577 - $86,819	10,962	10,962 $70,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.